本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Intellipharmaceutics Internation

0.2106
0.0000
成交量:- -
成交额:- -
市值:916.91万
市盈率:-0.60
高:0.2106
开:0.2106
低:0.2106
收:0.2106
数据加载中...
2021/03/31

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/03/30

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/01/21

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2019/11/18

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2019/06/03

交易所摘牌声明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2019/03/20

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/04

[修订]年度报告

[Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2019/03/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/01

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/22

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/20

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/28

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/07

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/05

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]